Diagnosis and management of psoriasis and psoriatic arthritis in adults: Summary of SIGN guidance

BMJ (Online)

Volumn 341, Issue 7780, 2010, Pages 987-989

  Burden, A D ^a   Hilton Boon, M ^b   Leman, J ^a   Wilson, H ^c   Richmond, R ^d   Ormerod, A D ^e,f  

^a WESTERN INFIRMARY   (United Kingdom)

^b Scottish Intercollegiate Guidelines Network (SIGN)   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

^d BORDERS GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PSORALEN; SALAZOSULFAPYRIDINE; SALICYLIC ACID; TAZAROTENE; USTEKINUMAB; VITAMIN D DERIVATIVE;

ARTICLE; HUMAN; NAIL PSORIASIS; PATIENT REFERRAL; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS GUTTATA; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; QUALITY OF LIFE; SCALP PSORIASIS; SKIN ATROPHY; ULTRAVIOLET A RADIATION;

ADULT; ARTHRITIS, PSORIATIC; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; REFERRAL AND CONSULTATION;

EID: 78049500697     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c5623     Document Type: Article

References (8)

1. Rapp SR, Feldman SR, Exum ML, Fleischer ABJr., Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41(3 Pt 1):401-7. [CrossRef] [Medline] [Web of Science]
2. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41. [Abstract/FREE Full text]
3. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008;159:895-902. [CrossRef] [Medline] [Web of Science]
4. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829-35. [CrossRef] [Medline] [Web of Science]
5. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005;6:383-92. [CrossRef] [Medline] [Web of Science]
6. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009;160:1040-7. [CrossRef] [Medline] [Web of Science]
7. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of psoriasis and psoriatic arthritis (SIGN guideline 121). 2010. www.sign.ac.uk/guidelines/fulltext/121/index.html.
8. Ibrahim G, Buch M, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and development of a new instrument: the psoriasis epidemiology screening tool (PEST) questionnaire. Clin Exp Rheumatol 2009;27:469-74. [Medline] [Web of Science]